Digital Biomarkers Could Reshape CNS Diagnosis, Treatment: AI drives new signal-detection efforts in Alzheimer's and ALS.

ALZHEIMER'S disease diagnosis; BIOMARKERS; ALZHEIMER'S disease; DIGITAL technology; PHARMACOLOGY; SERIAL publications; ARTIFICIAL intelligence; AMYOTROPHIC lateral sclerosis; ALGORITHMS

The article discusses how digital biomarkers, artificial intelligence (AI), machine learning, and algorithms could revolutionized the diagnosis and treatment of central nervous system (CNS) diseases like Alzheimer's disease and amyotrophic lateral sclerosis (ALS). According to Linus Health's David Bates, they are using AI and machine learning to improve the detection of said conditions. Also cited are how digital biomarkers are focusing on tracking physiological and behavioral data points.